Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission
BONE MARROW TRANSPLANTATION（2022）
Key words
Allogeneic hematopoietic stem cell transplantation,Minimal/measurable residual disease,Quantitative real-time PCR,Mixed chimerism,Multiparameter flow cytometry,Acute myelogenous leukemia
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined